PHARMACIE DU ROC

{
  "notary": {
    "name": "Marie-Christine DERONNE",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Tournai",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-02-21",
    "filing_date": "2024-02-18",
    "act_kind_objet": "MODIFICATION FORME JURIDIQUE, DEMISSIONS, NOMINATIONS, OBJET, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "act_date": "2023-12-29",
    "unanimous": true
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "full_restatement",
      "legal_form_change",
      "object_change",
      "wvv_adaptation"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "fr",
    "language_before": "nl"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0894.469.464",
    "name_full_after": "PHARMACIE DU ROC",
    "legal_form_after": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
    "name_full_before": "PHARMACIE DU ROC",
    "current_zetel_raw": "Place de Thimougies(TH) 18 : 7533 Tournai",
    "legal_form_before": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Examen et approbation du rapport \u00E9tabli par l\u2019organe d\u2019administration conform\u00E9ment \u00E0 l\u2019article 5:101 du Code des Soci\u00E9t\u00E9s et des associations.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5:101"
    },
    {
      "summary": "Suppression du compte de capitaux propres statutairement indisponible et mise \u00E0 disposition de ces fonds pour des distributions futures.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "39, \u00A72"
    },
    {
      "summary": "Octroi \u00E0 l\u2019organe d\u2019administration du pouvoir de proc\u00E9der \u00E0 des distributions provenant du b\u00E9n\u00E9fice de l\u0027exercice en cours ou du b\u00E9n\u00E9fice de l\u0027exercice pr\u00E9c\u00E9dent.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5:142"
    },
    {
      "summary": "Octroi \u00E0 l\u2019organe d\u2019administration du pouvoir de proc\u00E9der \u00E0 des distributions provenant du b\u00E9n\u00E9fice de l\u0027exercice en cours ou du b\u00E9n\u00E9fice de l\u0027exercice pr\u00E9c\u00E9dent.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5:143"
    }
  ],
  "governance_change": {
    "organ_kind_after": "enige_bestuurder",
    "organ_kind_before": "enige_bestuurder",
    "admin_delegated_added": [
      {
        "name": "Delphine DESMET",
        "excluded_powers": []
      },
      {
        "name": "BROUTA Fr\u00E9d\u00E9ric, Didier, Fabian",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": "enige_bestuurder",
    "co_signature_threshold_eur": null,
    "representation_rule_before": "enige_bestuurder"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Marie-Christine DERONNE",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "Exp\u00E9dition",
    "Rapport de l\u2019organe d\u2019administration",
    "Statuts coordonn\u00E9s"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": "L\u0027objet de la soci\u00E9t\u00E9 a \u00E9t\u00E9 reformul\u00E9 pour s\u0027adapter \u00E0 la nouvelle terminologie du Code des Soci\u00E9t\u00E9s et des associations, en \u00E9largissant son champ d\u0027activit\u00E9 pour favoriser son d\u00E9veloppement. L\u0027objet inclut d\u00E9sormais toutes op\u00E9rations industrielles, commerciales, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res se rapportant aux activit\u00E9s d\u0027exploitation d\u0027officines pharmaceutiques, ainsi que la fabrication et la commercialisation de produits pharmaceutiques, hom\u00E9opathiques et cosm\u00E9tologiques.",
  "capital_structure_change": {
    "operations": [
      "wvv_capital_release"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": null,
    "capital_before_eur": 18600.0,
    "share_classes_after": []
  },
  "coordinated_text_lineage": {
    "previous_ag_date": "2023-12-29",
    "previous_mb_reference": "ACP (5) Volume 000 Folio 000 Case 0399"
  }
}